drugset / Trial / NCT00111904

Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

NCT00111904 ↗

Phase 2 Completed 43 enrolled Theradex
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well paclitaxel works in treating patients with unresectable locally advanced or metastatic pancreatic cancer.

Timeline

Start
2005-05
Primary completion
2007-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 300 mg/m2 Intravenous
Subject Paclitaxel Small molecule 350 mg/m2 Intravenous
Subject Paclitaxel Small molecule 435 mg/m2 Intravenous